Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
| Lot / Report | Tested | Purity | Lab | Panels | Status | |
|---|---|---|---|---|---|---|
| RP052226 | Jun 2026 | 99.4% | Kovera Labs | Endotoxin, Sterility, Heavy metals | Confirmed | View |
The FDA PCAC advisory committee meets July 23–24, 2026 to review nominations and make recommendations on compounding eligibility — the PCAC is advisory only, and the FDA would issue any final rule on a separate, later timeline. CJC-1295 is on the proposed list. If the FDA subsequently issues a final rule, a valid prescription from a licensed prescriber may be required for compounding access; timing is uncertain. Disclosed Labs does not provide medical or legal advice.
Does Real Peptides sell CJC-1295?
Real Peptides has 5 COAs on file for CJC-1295 but no active price listing is currently tracked.
Is Real Peptides's CJC-1295 third-party tested?
Yes — Disclosed Labs has indexed 5 Certificates of Analysis for Real Peptides's CJC-1295, with the most recent showing 99.4% purity. Real Peptides holds an overall trust grade of B (83/100) across all 142 COAs on file.
What is Real Peptides's trust grade for CJC-1295?
Real Peptides has an overall Disclosed Labs trust grade of B (83/100), computed from 142 COAs across all peptides. The most recent CJC-1295 COA was issued by Kovera Labs.
Where is the cheapest CJC-1295?
As of the latest data, Peptide Supply Co. offers CJC-1295 at $3.80/mg — compare with Real Peptides's listing. See the full CJC-1295 price comparison.
Is CJC-1295 legal to buy?
CJC-1295 is among the peptides under FDA review for the Category 1 (503A) bulk-substances list — removed from Category 2 in April 2026 but not yet on a finalized Category 1 list. The FDA PCAC committee meets July 23–24, 2026 to make recommendations on which peptides may be compounded, and under what conditions — the PCAC is advisory only, and the FDA would issue any final rule on a separate, later timeline. If a final rule is ultimately issued, a valid prescription from a licensed prescriber may be required for compounding access; timing is uncertain. Current sales are for research purposes only. Disclosed Labs does not provide medical or legal advice.
| Black Cap | May 2026 | 99.3% | Freedom Diagnostics | — | Confirmed | View |
| — | Dec 2025 | — | BioRegen | Endotoxin | Confirmed | View |
| — | Dec 2025 | 99.7% | BioRegen | — | Unverified | View |
| BATCH-0322 | — | 99.5% | Kovera Labs | Endotoxin, Heavy metals | Unverified | View |